Sinohealth Holdings Limited (HKG:2361)

Market Cap	1.40B
Revenue (ttm)	429.64M
Net Income (ttm)	117.75M
Shares Out	408.09M
EPS (ttm)	0.29
PE Ratio	11.95
Forward PE	n/a
Dividend	0.12 (3.50%)
Ex-Dividend Date	Jun 23, 2025

Volume	6,500
Average Volume	5,075
Open	3.310
Previous Close	3.320
Day's Range	3.310 - 3.430
52-Week Range	2.240 - 5.500
Beta	-0.25
RSI	48.82
Earnings Date	Aug 25, 2025

About Sinohealth Holdings

Sinohealth Holdings Limited provides healthcare solutions for sales and marketing needs of medical product manufacturer clients in Mainland China, the Netherland, England, Hong Kong, Singapore, and internationally. It engages in the research and development, and provision of data insight solutions, data-driven publications and events, and software as a service (SaaS) products; research and development, and operation of Smart Medical Cloud under the business line of SaaS products; management of marketing and promotion services of medicine; opera...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2007
• Employees: 768
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2361

Financial Performance

In 2024, Sinohealth Holdings's revenue was 403.73 million, an increase of 1.90% compared to the previous year's 396.19 million. Earnings were 110.65 million, an increase of 8.45%.

Financial numbers in CNY